Cover Image

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults

There is an unmet medical need for vaccines to prevent dengue. V180 is an investigational recombinant subunit vaccine that consists of truncated dengue envelope proteins (DEN-80E) for all 4 serotypes. Three dosage levels of the tetravalent DEN-80E antigens were assessed in a randomized, placebo-cont...

Full description

Saved in:

Bibliographic Details
Main Authors:	Susan B. Manoff (Author), Michele Sausser (Author), Amy Falk Russell (Author), Jason Martin (Author), David Radley (Author), Donna Hyatt (Author), Christine C. Roberts (Author), Jason Lickliter (Author), Janakan Krishnarajah (Author), Andrew Bett (Author), Sheri Dubey (Author), Tyler Finn (Author), Beth-Ann Coller (Author)
Format:	Book
Published:	Taylor & Francis Group, 2019-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults
by: Kevin L. Russell, et al.
Published: (2022)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
by: Shibadas Biswal, et al.
Published: (2021)

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
by: Stephen S Whitehead, et al.
Published: (2017)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
by: Claire Vigne, et al.
Published: (2017)

Flavivirus Encephalitis
Published: (2011)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017)

Non-Flavivirus Encephalitis
Published: (2011)

Advances in Flavivirus Research
by: Michael R. Holbrook (Ed.)
Published: (2017)

Co-circulation of Aedes flavivirus, Culex flavivirus, and Quang Binh virus in Shanghai, China
by: Yuan Fang, et al.
Published: (2018)

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.
by: Stefan W Metz, et al.
Published: (2018)

Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020)

Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020)

Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants
by: Mikhail Petrovich Kostinov, et al.
Published: (2018)

Serological evidence of widespread circulation of West Nile virus and other flaviviruses in equines of the Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2014)

Development and evaluation of a tetravalent botulinum vaccine
by: Dan-Yang Shi, et al.
Published: (2022)

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
by: Michael L. Landrum, et al.
Published: (2017)

Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro
by: Rick Heida, et al.
Published: (2022)

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination
by: Patricia Kaaijk, et al.
Published: (2018)

Pathogenesis and Inhibition of Flaviviruses from a Carbohydrate Perspective
by: So Young Kim, et al.
Published: (2017)

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
by: Philippe J Guerin, et al.
Published: (2008)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019)

A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants
by: Lalitendu Mohanty, et al.
Published: (2017)

Powassan virus: A tick borne flavivirus infecting humans
by: Xu Yang, et al.
Published: (2022)

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses
by: Mônika A. Coronado, et al.
Published: (2023)

A recombinant live attenuated tetravalent vaccine for the prevention of dengue
by: Bruno Guy, et al.
Published: (2017)

One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study
by: Jialei Hu, et al.
Published: (2018)

Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine
by: William R. Lykins, et al.
Published: (2024)

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
by: Jason W Bennett, et al.
Published: (2016)

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
by: Vianney Tricou, et al.
Published: (2023)

Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue.
by: Cynthia Bernal, et al.
Published: (2023)

Efficacy of tetravalent dengue vaccine: A systematic review and meta-analysis
by: Ashish Wasudeo Khobragade, et al.
Published: (2021)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines.
by: Philip K Russell, et al.
Published: (2016)

The interface between methyltransferase and polymerase of NS5 is essential for flavivirus replication.
by: Xiao-Dan Li, et al.
Published: (2014)

Evaluation of serological test of Zika in an endemic area of flavivirus in the Colombian Caribbean
by: German Arrieta, et al.
Published: (2019)

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
by: Shrikant Sharma, et al.
Published: (2018)

The truncated form of flagellin (tFlic) provides the 2dCap subunit vaccine with better immunogenicity and protective effects in mice
by: Ying Lu, et al.
Published: (2022)

Incorporation of Escherichia coli heat-labile enterotoxin B subunit into rabies virus particles enhances its immunogenicity in mice and dogs
by: Zhiyuan Gong, et al.
Published: (2023)

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial
by: Sumantra Sarkar, et al.
Published: (2021)

A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis
by: Julia Tietz, et al.
Published: (2024)